346 related articles for article (PubMed ID: 32050835)
61. [NTRK-rearranged uterine sarcoma: a clinicopathological analysis of seven cases].
Huang HJ; Wang C; Fan DG; He YH; Chen X; Zheng SL
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):189-191. PubMed ID: 38281791
[No Abstract] [Full Text] [Related]
62. Uterine Sarcoma With EML4::NTRK3 Fusion: A Spectrum of Mesenchymal Neoplasms Harboring Actionable Gene Fusions.
de Castro JVA; Dos Santos PJS; Mantoan H; Baiocchi G; Bovolim G; Torrezan G; Corassa M; do Nascimento AG; De Brot M; Costa FD; De Brot L
Int J Gynecol Pathol; 2024 Jan; 43(1):56-60. PubMed ID: 37668341
[TBL] [Abstract][Full Text] [Related]
63. NTRK Fusion in a Cohort of BRAF p. V600E Wild-Type Papillary Thyroid Carcinomas.
Lee SE; Lee MS; Bang H; Kim MY; Choi YL; Oh YL
Mod Pathol; 2023 Aug; 36(8):100180. PubMed ID: 37003481
[TBL] [Abstract][Full Text] [Related]
64. Canadian consensus on TRK-inhibitor therapy for NTRK fusion-positive sarcoma.
Simmons C; Deyell RJ; MacNeill AJ; Vera-Badillo FE; Smrke A; Abdul Razak AR; Banerji S; McLeod D; Noujaim J
Int J Cancer; 2021 Nov; 149(9):1691-1704. PubMed ID: 34213775
[TBL] [Abstract][Full Text] [Related]
65. Uterine Neurotrophic Tyrosine Receptor Kinase Rearranged Spindle Cell Neoplasms: Three Cases of an Emerging Entity.
Grant L; Boyle W; Williams S; Pascoe J; Ganesan R
Int J Gynecol Pathol; 2024 Jul; 43(4):326-334. PubMed ID: 37922944
[TBL] [Abstract][Full Text] [Related]
66. Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment.
Chen W; Wang H; Jiang D; Luan L; Zhou Y; Hou Y
World J Surg Oncol; 2021 Apr; 19(1):136. PubMed ID: 33941195
[TBL] [Abstract][Full Text] [Related]
67. A recurrent NTRK1 tyrosine kinase domain mutation pair is characteristic in a subset of dedifferentiated liposarcomas.
Lippai Z; Péterfia B; Papp G; Dezső K; Bedics G; Pápai Z; Lamers MH; Kuin RC; Szuhai K; Sápi Z
Eur J Cancer; 2024 May; 202():114005. PubMed ID: 38531265
[TBL] [Abstract][Full Text] [Related]
68. [Clinicopathological and molecular characteristics of NTRK-rearranged spindle cell neoplasms in the gastrointestinal tract].
Jian XY; Gao HQ; Zhao ZH; Wang F; Zhang L; Ma YH
Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):598-604. PubMed ID: 38825906
[No Abstract] [Full Text] [Related]
69. Intestinal
Rahim S; Alkhaldi SS; Alasousi K; Ali RH
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36357104
[TBL] [Abstract][Full Text] [Related]
70. Frequent CD30 Expression in an Emerging Group of Mesenchymal Tumors With NTRK, BRAF, RAF1, or RET Fusions.
Kojima N; Mori T; Motoi T; Kobayashi E; Yoshida M; Yatabe Y; Ichikawa H; Kawai A; Yonemori K; Antonescu CR; Yoshida A
Mod Pathol; 2023 Apr; 36(4):100083. PubMed ID: 36788089
[TBL] [Abstract][Full Text] [Related]
71. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
Rudzinski ER; Lockwood CM; Stohr BA; Vargas SO; Sheridan R; Black JO; Rajaram V; Laetsch TW; Davis JL
Am J Surg Pathol; 2018 Jul; 42(7):927-935. PubMed ID: 29683818
[TBL] [Abstract][Full Text] [Related]
72. NTRK Gene Fusion Detection in Atypical Spitz Tumors.
Cappellesso R; Nozzoli F; Zito Marino F; Simi S; Castiglione F; De Giorgi V; Cota C; Senetta R; Scognamiglio G; Anniciello AM; Cesinaro AM; Mandalà M; Gianatti A; Valente MG; Valeri B; Sementa AR; Ricci C; Corti B; Roviello G; Dei Tos AP; Franco R; Massi D
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830218
[TBL] [Abstract][Full Text] [Related]
73. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network.
Demetri GD; Antonescu CR; Bjerkehagen B; Bovée JVMG; Boye K; Chacón M; Dei Tos AP; Desai J; Fletcher JA; Gelderblom H; George S; Gronchi A; Haas RL; Hindi N; Hohenberger P; Joensuu H; Jones RL; Judson I; Kang YK; Kawai A; Lazar AJ; Le Cesne A; Maestro R; Maki RG; Martín J; Patel S; Penault-Llorca F; Premanand Raut C; Rutkowski P; Safwat A; Sbaraglia M; Schaefer IM; Shen L; Serrano C; Schöffski P; Stacchiotti S; Sundby Hall K; Tap WD; Thomas DM; Trent J; Valverde C; van der Graaf WTA; von Mehren M; Wagner A; Wardelmann E; Naito Y; Zalcberg J; Blay JY
Ann Oncol; 2020 Nov; 31(11):1506-1517. PubMed ID: 32891793
[TBL] [Abstract][Full Text] [Related]
74. The Pan-TRK Antibody is a Sensitive and Specific Tool for the Detection of NTRK Fusion Genes.
Bautista-Wong C; Mojica-González Z; Hop-Garcia K; Bornstein Quevedo L
Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):213-216. PubMed ID: 37017998
[TBL] [Abstract][Full Text] [Related]
75. Identification of NTRK fusions in pediatric mesenchymal tumors.
Pavlick D; Schrock AB; Malicki D; Stephens PJ; Kuo DJ; Ahn H; Turpin B; Allen JM; Rosenzweig M; Badizadegan K; Ross JS; Miller VA; Wong V; Ali SM
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28097808
[TBL] [Abstract][Full Text] [Related]
76. ALK rearrangements in infantile fibrosarcoma-like spindle cell tumours of soft tissue and kidney.
Tan SY; Al-Ibraheemi A; Ahrens WA; Oesterheld JE; Fanburg-Smith JC; Liu YJ; Spunt SL; Rudzinski ER; Coffin C; Davis JL
Histopathology; 2022 Mar; 80(4):698-707. PubMed ID: 34843129
[TBL] [Abstract][Full Text] [Related]
77. RAF1-rearranged spindle cell tumour: report of two additional cases with identification of a novel FMR1-RAF1 fusion.
Zhang T; Wang Q; Yi X; Zhu P
Virchows Arch; 2021 Dec; 479(6):1245-1253. PubMed ID: 34459981
[TBL] [Abstract][Full Text] [Related]
78. The first case of gastric carcinoma with NTRK rearrangement: identification of a novel ATP1B-NTRK1 fusion.
Shinozaki-Ushiku A; Ishikawa S; Komura D; Seto Y; Aburatani H; Ushiku T
Gastric Cancer; 2020 Sep; 23(5):944-947. PubMed ID: 32189226
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics.
Hung YP; Fletcher CDM; Hornick JL
Histopathology; 2018 Oct; 73(4):634-644. PubMed ID: 29863809
[TBL] [Abstract][Full Text] [Related]
80. Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations.
Klubíčková N; Dermawan JK; Mosaieby E; Martínek P; Vaněček T; Hájková V; Ptáková N; Grossmann P; Šteiner P; Švajdler M; Kinkor Z; Michalová K; Szepe P; Plank L; Hederová S; Kolenová A; Spasov NJ; Kosemehmetoglu K; Pažanin L; Špůrková Z; Baník M; Baumruk L; Meyer A; Kalmykova A; Koshyk O; Michal M; Michal M
J Pathol; 2024 May; 263(1):61-73. PubMed ID: 38332737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
